Williams & Novak LLC Grows Stock Holdings in Avanos Medical, Inc. $AVNS

Williams & Novak LLC increased its position in Avanos Medical, Inc. (NYSE:AVNS) by 71.3% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 22,219 shares of the company’s stock after acquiring an additional 9,250 shares during the period. Williams & Novak LLC’s holdings in Avanos Medical were worth $272,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. State of Wyoming lifted its position in Avanos Medical by 104.6% in the 1st quarter. State of Wyoming now owns 10,508 shares of the company’s stock valued at $151,000 after acquiring an additional 5,371 shares in the last quarter. EntryPoint Capital LLC bought a new position in shares of Avanos Medical during the first quarter valued at $181,000. EP Wealth Advisors LLC lifted its holdings in shares of Avanos Medical by 46.3% during the first quarter. EP Wealth Advisors LLC now owns 14,783 shares of the company’s stock valued at $212,000 after purchasing an additional 4,675 shares in the last quarter. US Bancorp DE lifted its holdings in shares of Avanos Medical by 7.7% during the first quarter. US Bancorp DE now owns 15,184 shares of the company’s stock valued at $218,000 after purchasing an additional 1,091 shares in the last quarter. Finally, Cary Street Partners Financial LLC bought a new position in shares of Avanos Medical during the first quarter valued at $226,000. 95.17% of the stock is owned by institutional investors.

Insider Activity

In other Avanos Medical news, Director Gary Blackford acquired 40,000 shares of the business’s stock in a transaction dated Wednesday, August 13th. The stock was purchased at an average price of $10.99 per share, with a total value of $439,600.00. Following the transaction, the director directly owned 40,000 shares in the company, valued at approximately $439,600. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 2.64% of the stock is currently owned by insiders.

Avanos Medical Stock Performance

AVNS opened at $10.73 on Friday. The company has a current ratio of 2.64, a quick ratio of 1.58 and a debt-to-equity ratio of 0.12. The company has a market cap of $497.87 million, a price-to-earnings ratio of -1.07 and a beta of 1.15. The company’s 50 day moving average is $11.60 and its 200 day moving average is $12.16. Avanos Medical, Inc. has a 12-month low of $9.30 and a 12-month high of $23.68.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.01). The business had revenue of $175.00 million during the quarter, compared to analysts’ expectations of $165.50 million. Avanos Medical had a positive return on equity of 6.16% and a negative net margin of 66.89%.During the same period in the previous year, the business posted $0.34 EPS. Avanos Medical has set its FY 2025 guidance at 0.750-0.950 EPS. On average, equities research analysts predict that Avanos Medical, Inc. will post 1.32 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on AVNS shares. Zacks Research raised shares of Avanos Medical to a “hold” rating in a report on Tuesday, August 12th. Wall Street Zen lowered shares of Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Avanos Medical in a research report on Saturday, September 27th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.